These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 34016734)

  • 1. COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review.
    Barzegar M; Mirmosayyeb O; Gajarzadeh M; Afshari-Safavi A; Nehzat N; Vaheb S; Shaygannejad V; Maghzi AH
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34016734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
    Safavi F; Nourbakhsh B; Azimi AR
    Mult Scler Relat Disord; 2020 Aug; 43():102195. PubMed ID: 32460086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
    Sormani MP; De Rossi N; Schiavetti I; Carmisciano L; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Trojano M; Zaratin P; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M;
    Ann Neurol; 2021 Apr; 89(4):780-789. PubMed ID: 33480077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.
    Czarnowska A; Brola W; Zajkowska O; Rusek S; Adamczyk-Sowa M; Kubicka-Bączyk K; Kalinowska-Łyszczarz A; Kania K; Słowik A; Wnuk M; Marona M; Podlecka-Piętowska A; Nojszewska M; Zakrzewska-Pniewska B; Jasińska E; Gołuch K; Lech B; Noga M; Perenc A; Popiel M; Lasek-Bal A; Puz P; Maciejowska K; Kucharska-Lipowska M; Lipowski M; Kapica-Topczewska K; Chorąży M; Tarasiuk J; Kochanowicz J; Kulikowska J; Wawrzyniak S; Niezgodzińska-Maciejek A; Pokryszko-Dragan A; Gruszka E; Budrewicz S; Białek M; Kurkowska-Jastrzębska I; Kurowska K; Stępień A; Włodek A; Ptasznik V; Pawełczyk M; Sobolewski P; Lejmel H; Strzalińska K; Maciejowski M; Tutaj A; Zwiernik J; Litwin A; Lewańczyk B; Paprocka I; Zwiernik B; Pawlos A; Borysowicz A; Narożnik A; Michałowska A; Nosek K; Fudala M; Milewska-Jędrzejczak M; Kułakowska A; Bartosik-Psujek H
    Neurol Neurochir Pol; 2021; 55(2):212-222. PubMed ID: 33856686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit.
    Sepúlveda M; Llufriu S; Martínez-Hernández E; Català M; Artola M; Hernando A; Montejo C; Pulido-Valdeolivas I; Martínez-Heras E; Guasp M; Solana E; Llansó L; Escudero D; Aldea M; Prats C; Graus F; Blanco Y; Saiz A
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33504634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis.
    Moghadasi AN; Mirmosayyeb O; Barzegar M; Sahraian MA; Ghajarzadeh M
    Neurol Sci; 2021 Aug; 42(8):3093-3099. PubMed ID: 34100130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review.
    Capone F; Motolese F; Luce T; Rossi M; Magliozzi A; Di Lazzaro V
    Mult Scler Relat Disord; 2021 Feb; 48():102734. PubMed ID: 33429305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.
    Arrambide G; Llaneza-González MÁ; Costa-Frossard França L; Meca-Lallana V; Díaz EF; Moreno-Torres I; García-Domínguez JM; Ortega-Suero G; Ayuso-Peralta L; Gómez-Moreno M; Sotoca-Fernández JJ; Caminero-Rodríguez AB; Rodríguez de Antonio LA; Corujo-Suárez M; Otano-Martínez MA; Pérez-Miralles FC; Reyes-Garrido V; Ayuso-Blanco T; Balseiro-Gómez JJ; Muñoz-Pasadas M; Pérez-Molina I; Arnal-García C; Domingo-Santos Á; Guijarro-Castro C; Íñiguez-Martínez C; Téllez Lara N; Castellanos-Pinedo F; Castillo-Triviño T; Cerdán-Santacruz DM; Pérez-Sempere Á; Torres BS; Álvarez de Arcaya A; Costa-Arpín E; Durán-Ferreras E; Fragoso-Martínez M; González-Platas M; Landete Pascual L; Millán-Pascual J; Oreja-Guevara C; Meca-Lallana JE
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34168057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients.
    Mallucci G; Zito A; Baldanti F; Gastaldi M; Fabbro BD; Franciotta D; Bergamaschi R
    Mult Scler Relat Disord; 2021 Apr; 49():102754. PubMed ID: 33609958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis.
    Mirmosayyeb O; Barzegar M; Nehzat N; Shaygannejad V; Sahraian MA; Ghajarzadeh M
    J Clin Neurosci; 2020 Sep; 79():33-38. PubMed ID: 33070914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based study.
    Barzegar M; Sindarreh S; Manteghinejad A; Mirmosayyeb O; Mazaheri S; Rahimi M; Javanmard SH; Shaygannejad V; Nasirian M
    Mult Scler Relat Disord; 2023 Nov; 79():104947. PubMed ID: 37659351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    Bsteh G; Assar H; Hegen H; Heschl B; Leutmezer F; Di Pauli F; Gradl C; Traxler G; Zulehner G; Rommer P; Wipfler P; Guger M; Enzinger C; Berger T;
    PLoS One; 2021; 16(7):e0255316. PubMed ID: 34314457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
    Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
    Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients.
    Mantero V; Abate L; Balgera R; Basilico P; Salmaggi A; Cordano C
    Mult Scler Relat Disord; 2020 Nov; 46():102453. PubMed ID: 32835900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis.
    Sahraian MA; Azimi A; Navardi S; Ala S; Naser Moghadasi A
    Mult Scler Relat Disord; 2020 Nov; 46():102472. PubMed ID: 32890817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MuSC-19 study: The Egyptian cohort.
    Zakaria M; Ponzano M; Schiavetti I; Carmisciano L; Nada M; AbdelNaseer M; Zamzam D; Masoud J; Aref H; Shalaby N; AbdelNaser A; Hamdy S; Saad M; Shehata H; Aly M; Kishk N; Hamdy E; Hassan A; Hashish A; Ahmed S; Foad M; Sormani MP
    Mult Scler Relat Disord; 2021 Nov; 56():103324. PubMed ID: 34656933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gluten in multiple sclerosis: A systematic review.
    Thomsen HL; Jessen EB; Passali M; Frederiksen JL
    Mult Scler Relat Disord; 2019 Jan; 27():156-163. PubMed ID: 30384202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East.
    Alroughani R; Inshasi J; Al-Hashel J; Alkhaboury J; Alsalti A; Al Suwaidi R; Hassino LH; Farouk Ahmed S
    J Clin Neurosci; 2022 May; 99():311-316. PubMed ID: 35339046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis.
    Ghajarzadeh M; Mohammadi A; Sahraian MA
    Autoimmun Rev; 2020 Oct; 19(10):102650. PubMed ID: 32801049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological profile of children and adolescents with COVID-19: a scoping review.
    Bernardino FBS; Alencastro LCDS; Silva RAD; Ribeiro ADDN; Castilho GRC; Gaíva MAM
    Rev Bras Enferm; 2021; 74Suppl 1(Suppl 1):e20200624. PubMed ID: 33533805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.